Christopher R. Hibberd
United States of America
Christopher R. Hibberd is the Co-Founder and Chief Executive Officer of Astute Medical Inc., a developer of biomarker-based diagnostics intended to help physicians rapidly identify and treat acute conditions for critically ill patients. Mr. Hibberd has more than 20 years’ experience as a leader in business strategy and corporate development. Prior to the founding of Astute Medical in 2007, Mr. Hibberd spent 10 years at Biosite Incorporated, a leading diagnostics company acquired by Inverness Medical Innovations for $1.7 billion. As Senior Vice-President of Corporate Development at Biosite, Mr. Hibberd was co-responsible for the identification and pursuit of strategic business opportunities, including technology acquisitions, partnerships and alliances.